Document is current

GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection

Crossref DOI link: https://doi.org/10.1007/5584_2020_494

Published Online: 2020-02-08

Published Print: 2020

Update policy: https://doi.org/10.1007/springer_crossmark_policy